Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -106.84 | 37.05 |
| PEG Ratio (TTM) | -1.74 | 11.98 |
| P/S Ratio (TTM) | 1.44 | 14.61 |
| P/B Ratio (TTM) | 2.41 | 18.78 |
| P/FCF Ratio (TTM) | 27.63 | 42.97 |
| Price to 5YR AVG Earnings Ratio | -26.07 | 32.96 |
| Price to 5YR AVG FCF Ratio | 39.94 | 63.36 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.95% | 12.20% |
| ROE (TTM) | -2.29% | -7.48% |
| Net Profit Margin (TTM) | -1.35% | 24.97% |
| ROIC 5YR AVG | -5.65% | 4.50% |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.25% | 16.17% | -169.02% |
| Revenue | 2.33% | 3.12% | -4.88% |
| Net Income | -7.05% | 12.43% | -169.79% |
| Cash Flow | 589.31% | -21.71% | -275.61% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.33 | 1.43 |
| Quick Ratio (TTM) | 1.21 | 1.41 |
| D/E Ratio (TTM) | 0.15 | 1.24 |
| Interest Coverage (TTM) | -211.33 | 35.48 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.49 | 9.32 |
| LTL to 5YR AVG FCF | 2.35 | 5.27 |
| Shares Outstanding Growth 5YR AVG | 1.40% | 0.66% |